Chiari malformation type I: what information from the genetics?
Autosomal dominant/recessive inheritance
Chiari type I malformation (CMI)
Hindbrain
Posterior cranial fossa (PCF)
Syringomyelia (SM)
Tonsillar ectopia
Whole exome sequencing (WES)
Journal
Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
ISSN: 1433-0350
Titre abrégé: Childs Nerv Syst
Pays: Germany
ID NLM: 8503227
Informations de publication
Date de publication:
10 2019
10 2019
Historique:
received:
01
04
2019
accepted:
28
07
2019
pubmed:
7
8
2019
medline:
24
10
2020
entrez:
7
8
2019
Statut:
ppublish
Résumé
Chiari malformation type I (CMI), a rare disorder of the craniocerebral junction with an estimated incidence of 1 in 1280, is characterized by the downward herniation of the cerebellar tonsils of at least 5 mm through the foramen magnum, resulting in significant neurologic morbidity. Classical CMI is thought to be caused by an underdeveloped occipital bone, resulting in a posterior cranial fossa which is too small to accommodate the normal-sized cerebellum. In this review, we dissect the lines of evidence supporting a genetic contribution for this disorder. We present the results of two types of approaches: animal models and human studies encompassing different study designs such as whole genome linkage analysis, case-control association studies, and expression studies. The update of the literature also includes the most recent findings emerged by whole exome sequencing strategy. Despite evidence for a genetic component, no major genes have been identified and the genetics of CMI is still very much unknown. One major challenge is the variability of clinical presentation within CMI patient population that reflects an underlying genetic heterogeneity. The identification of the genes that contribute to the etiology of CMI will provide an important step to the understanding of the underlying pathology. The finding of a predisposing gene may lead to the development of simple and accurate diagnostic tests for better prognosis, counseling, and clinical management of patients and their relatives.
Identifiants
pubmed: 31385087
doi: 10.1007/s00381-019-04322-w
pii: 10.1007/s00381-019-04322-w
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1665-1671Subventions
Organisme : Ministero della Salute
ID : Ricerca Corrente 2016
Pays : International
Références
Neurosurgery. 1999 May;44(5):1005-17
pubmed: 10232534
J Neurosurg. 2000 Jun;92(6):920-6
pubmed: 10839250
Br J Neurosurg. 2001 Jun;15(3):279-80
pubmed: 11478071
Dev Cell. 2001 Sep;1(3):423-34
pubmed: 11702953
J Neurosurg. 2002 Aug;97(2):396-400
pubmed: 12186468
Pediatrics. 2002 Dec;110(6):1212-9
pubmed: 12456921
Vet Rec. 2003 Jul 26;153(4):107-12
pubmed: 12918827
J Am Acad Nurse Pract. 2004 Mar;16(3):134-8
pubmed: 15130068
Oncogene. 2004 Nov 4;23(52):8520-6
pubmed: 15378020
J Vet Intern Med. 2004 Sep-Oct;18(5):673-8
pubmed: 15515584
Radiology. 1992 May;183(2):347-53
pubmed: 1561334
Ann Neurol. 1992 Feb;31(2):220-2
pubmed: 1575461
Hum Mol Genet. 2005 Nov 15;14(22):3523-38
pubmed: 16207730
Clin Genet. 1992 Jan;41(1):12-5
pubmed: 1633640
Oral Dis. 2006 Mar;12(2):102-11
pubmed: 16476029
Neurosurg Focus. 2000 Mar 15;8(3):E12
pubmed: 16676924
Am J Med Genet A. 2006 Dec 15;140(24):2776-85
pubmed: 17103432
Int J Biochem Cell Biol. 2008;40(9):1659-63
pubmed: 17656144
J Neurosurg Spine. 2007 Dec;7(6):601-9
pubmed: 18074684
Nature. 1991 Jul 25;352(6333):337-9
pubmed: 1852208
J Neurosurg. 2009 Nov;111(5):1046-52
pubmed: 19463049
Nature. 2009 Sep 10;461(7261):272-6
pubmed: 19684571
PLoS One. 2009 Nov 20;4(11):e7930
pubmed: 19936252
BMC Musculoskelet Disord. 2009 Dec 17;10 Suppl 1:S1
pubmed: 20018097
Acta Neurochir (Wien). 2010 Jul;152(7):1117-27
pubmed: 20440631
J Neurosurg Pediatr. 2011 Mar;7(3):248-56
pubmed: 21361762
J Cell Biochem. 2011 Dec;112(12):3491-501
pubmed: 21793042
Nat Rev Genet. 2011 Sep 27;12(11):745-55
pubmed: 21946919
PLoS One. 2013;8(2):e57241
pubmed: 23437350
PLoS One. 2013 Apr 19;8(4):e61521
pubmed: 23620759
Ann Hum Genet. 2014 Jan;78(1):1-12
pubmed: 24359474
PLoS One. 2014 Apr 16;9(4):e89816
pubmed: 24740420
BMC Genomics. 2015 Jan 22;16:11
pubmed: 25609184
J Genet Couns. 2003 Aug;12(4):297-311
pubmed: 26141174
Genes Dev. 2015 Jul 15;29(14):1463-86
pubmed: 26220993
Childs Nerv Syst. 2015 Dec;31(12):2217-23
pubmed: 26280629
Genes Dev. 2016 Apr 1;30(7):751-71
pubmed: 27036966
Semin Cell Dev Biol. 2017 Feb;62:34-49
pubmed: 27771362
Eur J Hum Genet. 2017 Aug;25(8):952-959
pubmed: 28513615
Sci Rep. 2017 Nov 9;7(1):15224
pubmed: 29123202
BMC Genet. 2018 Mar 22;19(1):16
pubmed: 29566674
AJNR Am J Neuroradiol. 1986 Sep-Oct;7(5):795-9
pubmed: 3096099
Neurofibromatosis. 1988;1(5-6):299-305
pubmed: 3152482
J Neurol Sci. 1981 Apr;50(1):29-55
pubmed: 7229658
Pediatr Neurol. 1995 Jan;12(1):84-8
pubmed: 7748369
Radiology. 1995 Jun;195(3):733-8
pubmed: 7754003
J Neurosurg. 1995 Mar;82(3):497-500
pubmed: 7861232
J Pediatr. 1994 Jul;125(1):29-35
pubmed: 8021781
Clin Pediatr (Phila). 1993 Mar;32(3):189-90
pubmed: 8453842
Intensive Care Med. 1993;19(2):73-4
pubmed: 8486872
Neurology. 1996 Feb;46(2):577-82
pubmed: 8614541
An Med Interna. 1997 Oct;14(10):519-22
pubmed: 9424143
Neurosurgery. 1998 May;42(5):1168-71
pubmed: 9588565
AJNR Am J Neuroradiol. 1998 Oct;19(9):1609-15
pubmed: 9802480